Contineum Therapeutics, Inc. (CTNM)

Contineum Therapeutics Statistics

Total Valuation

CTNM has a market cap or net worth of $532.22 million. The enterprise value is $414.89 million.

Market Cap	532.22M
Enterprise Value	414.89M

Important Dates

The next estimated earnings date is Friday, August 16, 2024, before market open.

Earnings Date	Aug 16, 2024
Ex-Dividend Date	n/a

Share Statistics

CTNM has 25.72 million shares outstanding.

Shares Outstanding	25.72M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.64
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.20

Current Ratio	19.20
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	$1.61M
Profits Per Employee	-$14,419
Employee Count	31
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	16.47
200-Day Moving Average	n/a
Relative Strength Index (RSI)	61.46
Average Volume (20 Days)	154,136

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CTNM had revenue of $50.00 million and -$447,000 in losses. Loss per share was -$0.02.

Revenue	50.00M
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	-447,000
EBITDA	n/a
EBIT	n/a
Loss Per Share	-$0.02

Balance Sheet

The company has $117.91 million in cash and $585,000 in debt, giving a net cash position of $117.32 million or $4.56 per share.

Cash & Cash Equivalents	117.91M
Total Debt	585,000
Net Cash	117.32M
Net Cash Per Share	$4.56
Equity (Book Value)	-75.63M
Book Value Per Share	-2.94
Working Capital	113.48M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	-0.89%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.08%
FCF Yield	n/a

Analyst Forecast

The average price target for CTNM is $28.00, which is 35.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.00
Price Target Difference	35.33%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a